Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Major European launch for Otsuka antithrombotic agent

July 31, 2002

Thrombin receptor antagonists designed at Merck

July 26, 2002

New antithrombin agents designed by AstraZeneca scientists

July 23, 2002

Yamanouchi scientists design series of anticoagulants

July 19, 2002

Pharmion acquires U.S. marketing rights to Innohep

July 19, 2002

GTC Biotherapeutics completes rhATIII study

July 17, 2002

Serine protease inhibitors with anticoagulant activity described by Pharmacia

July 16, 2002

Novel factor Xa inhibitor and oral prodrug presented at IUPHAR 2002 by Kissei

July 15, 2002

Antiplatelet/antithrombotic efficacy demonstrated for P2Y12 receptor antagonists

July 15, 2002

BMS claims serine protease inhibitors with anticoagulant activity

July 12, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...